Haleon PE Ratio 2023-2024 | HLN
Current and historical p/e ratio for Haleon (HLN) from 2023 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Haleon PE ratio as of June 11, 2025 is 27.92.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Haleon PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-11 | 10.91 | 30.31 | |
| 2024-09-30 | 10.46 | $0.36 | 29.06 |
| 2024-06-30 | 8.12 | $0.32 | 25.38 |
| 2024-03-31 | 8.35 | $0.32 | 26.09 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $49.016B | $14.355B |
| Haleon plc engages in the research and development, manufacture and sale of various consumer healthcare products principally in North America, Europe, the Middle East, Africa, Latin America and the Asia Pacific. It provides therapeutic oral health, pain relief, respiratory health, digestive health and other products, as well as vitamins, minerals and supplements. Haleon plc is based in Brentford, the United Kingdom. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.364B | 28.06 |
| Stryker (SYK) | United States | $146.969B | 30.73 |
| Boston Scientific (BSX) | United States | $146.968B | 36.79 |
| EssilorLuxottica (ESLOY) | France | $131.277B | 0.00 |
| Medtronic (MDT) | Ireland | $112.813B | 15.99 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.710B | 0.00 |
| ResMed (RMD) | United States | $37.047B | 27.83 |
| Agilent Technologies (A) | United States | $34.235B | 22.32 |
| GE HealthCare Technologies (GEHC) | United States | $33.847B | 16.07 |
| Terumo (TRUMY) | Japan | $26.946B | 35.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.399B | 16.10 |
| Insulet (PODD) | United States | $21.023B | 82.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.780B | 12.06 |
| Baxter (BAX) | United States | $16.278B | 12.15 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.165B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.273B | 21.83 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $4.281B | 19.13 |
| Perrigo (PRGO) | Ireland | $3.794B | 9.62 |
| Haemonetics (HAE) | United States | $3.466B | 15.79 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.367B | 24.83 |
| Envista Holdings (NVST) | United States | $3.244B | 26.96 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.091B | 14.38 |
| LeMaitre Vascular (LMAT) | United States | $1.890B | 42.24 |
| AtriCure (ATRC) | United States | $1.653B | 0.00 |
| Acuren (TIC) | United States | $1.314B | 0.00 |
| Neogen (NEOG) | United States | $1.268B | 16.22 |
| AdaptHealth (AHCO) | United States | $1.190B | 12.08 |
| BioLife Solutions (BLFS) | United States | $1.136B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.063B | 23.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.053B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.987B | 12.61 |
| InMode (INMD) | Israel | $0.920B | 9.27 |
| CeriBell (CBLL) | United States | $0.640B | 0.00 |
| Evolus (EOLS) | United States | $0.636B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.634B | 0.00 |
| Owens & Minor (OMI) | United States | $0.629B | 5.22 |
| Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.422B | 0.00 |
| Surmodics (SRDX) | United States | $0.418B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.367B | 13.50 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.334B | 59.50 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.283B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.276B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.00 |
| ZimVie (ZIMV) | United States | $0.266B | 12.09 |
| Sanara MedTech (SMTI) | United States | $0.265B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.264B | 0.00 |
| Quanterix (QTRX) | United States | $0.256B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.253B | 0.00 |
| Omeros (OMER) | United States | $0.227B | 0.00 |
| Biote (BTMD) | United States | $0.227B | 6.37 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Brainsway (BWAY) | Israel | $0.216B | 57.30 |
| TriSalus Life Sciences (TLSI) | United States | $0.211B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.16 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.105B | 0.00 |
| Veru (VERU) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.88 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.074B | 0.00 |
| Apyx Medical (APYX) | United States | $0.069B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.43 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |